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Summary
Propensity score methods are increasingly being used to reduce estimation bias of
treatment effects for observational studies. Previous research has shown that propen-
sity score methods consistently estimate the marginal hazard ratio for time to event
data. However, recurrent data frequently arise in the biomedical literature and there
is a paucity of research into the use of propensity score methods when data are recur-
rent in nature. The objective of this paper is to extend the existing propensity score
methods to recurrent data setting.We illustrate ourmethods througha series ofMonte
Carlo simulations. The simulation results indicate that without the presence of cen-
soring, the IPTW estimators allow us to consistently estimate the marginal hazard
ratio for each event. Under administrative censoring regime, the stabilized IPTW
estimator yields biased estimate of the marginal hazard ratio, and the degree of bias
depends on the proportion of subjects being censored. For variance estimation, the
naÃŕve variance estimator often tends to substantially underestimate the variance
of the IPTW estimator, while the robust variance estimator significantly reduces the
estimation bias of the variance.
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1 INTRODUCTION
Causal inference is an emerging field in statistics. In medical research, we are often interested in understanding the effect of
treatment on an outcome. The gold standard is to conduct an experimental study where treatment is randomized. However,
observational studies frequently arise in medical research, in which treatment assignment is often related to characteristics of
patients. As a result, the characteristics of treatment and control group may be systematically different. To this end, adjustments
must be made to balance the covariates between the two groups. Over the past several decades, different methods for making
causal inference with observational data have been developed and there has been an increasing interest in using the propensity
score methods. The propensity score is defined as the probability of treatment assignment conditional on measured baseline
covariates1. There are four propensity score methods that are used most often in the biomedical literature: matching, stratifi-
cation, inverse probability weighting and covariate adjustment. These methods allow us to reconstruct a pseudo-sample which
reflects an experimental data setting, thus reducing or eliminating bias in estimating the treatment effect.
In the 1980’s, researchers mainly focused on bias reduction on a linear scale. Rosenbaum and Rubin (1983) demonstrated that
by dividing the sample into five mutually exclusive equal-sized strata based on the propensity score would result in an over 90%
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bias reduction when the treatment is an average treatment effect (ATE)1,2. In addition to that, the inverse probability treatment
weighting method using the propensity score was proven to unbiasedly estimate the average treatment effect (ATE)1. It was not
until recent years that propensity score methods for non-linear measures of treatment effects received attention. Some applied
researchers tried to use propensity score methods to estimate non-linear treatment effects such as odds ratio and hazard ratio.
However, the degree of bias incurred had not been extensively studied3. It was not until the beginning of the 21푠푡 century that
Austin (2007) performed a series of Monte Carlo simulation studies to examine the degree of bias when treatment effects are
measured using a hazard ratio, odds ratio and rate ratio3. The simulation results indicated that conditional on the propensity score,
matching, stratification and inverse probability weighting all resulted in biased estimates of the true conditional hazard ratio and
odds ratio. Interestingly the rate ratio was consistently estimated for all propensity score methods. This is because conditional on
the propensity score, we estimate the marginal treatment effect instead of the conditional treatment effect4. A conditional effect
refers to the average effect at the individual level, of removing a subject from treated to untreated. The regression coefficient
of treatment indicator in a Cox proportional hazards model is a conditional effect5. A marginal effect is the average effect at
the population level, of moving the whole population from treated to untreated6. For randomized controlled trials, we estimate
the marginal effect by using the Cox proportional hazard model with treatment indicator as the only covariate. Austin (2007)
concluded that the marginal treatment effect coincides with the conditional treatment effect when the measure of treatment effect
is a difference in means or rate ratio while they do not coincide when the measure of treatment effect is odds ratio or hazard
ratio3 7.
Many observational data in real life are recurrent in nature. We already know that the propensity score methods estimate the
marginal hazard ratio for time to event data5. However, there is a paucity of research on making causal inference for recurrent
data. Hence it would be desirable to extend the propensity score framework to two events an possibly multiple events. Therefore,
the objective of this paper is to formulate appropriate propensity score methods to estimate the treatment effect in the context
of recurrent data.
2 METHODS
In this section we investigate the inverse probability of treatment weighting method (IPTW) for estimating treatment effects
when there are two events for each subject. Three scenarios are discussed in this section: independent gap times, time-varying
covariates with fixed treatment and time-varying covariates with time-varying treatment8. For each scenario, model assumptions
and specifications of the treatment model and the outcome model are given.
2.1 Notation and Model Setup
We use the following notation throughout this chapter. Assume there are 푛 subjects 푖 = 1, 2, ..., 푛 although we suppress 푖 notation
in this chapter. Let 푋(푗) be a 푝-dimensional vector of covariates at the start of the 푗푡ℎ gap time and 푍(푗) be treatment status at
the start of the 푗푡ℎ gap time. Let푊1 denote the first gap time and푊2 denote the second gap time. We define the propensity score
for the first event 푒1 to be
푒1 = 푃 (푍(1) = 1|푋(1) = 푥(1))
We define 푒2 to be the propensity score for the second gap time i.e. the probability of treatment for the second event conditional
on all past covariate and treatment history. That is,
푒2 = 푃 (푍(2) = 1|푋(2) = 푥(2), 푍(1) = 푧(1))
where푋(푗) = (푋(1), 푋(2), ...푋(푗)) is the covariate history through the start of the 푗푡ℎ gap time and푍(푗) = (푍(1), 푍(2), ...푍(푗))
is the treatment history through the start of the 푗푡ℎ gap time. Hence, the probability of a subject receive treatment for both events
conditional on all past history is:
푒1푒2 = 푃 (푍(1) = 1, 푍(2) = 1|푋(2) = 푥(2), 푍(1) = 푧(1))
= 퐸(푍(1)푍(2)|푋(2) = 푥(2), 푍(1) = 푧(1))
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Intuitively, the IPTWweights are defined to be the inverse of the probability of treatment path conditional on all past treatment
and covariate history. The stabilized inverse probability treatment weights are9
푠푤1 =
푃 (푍(1) = 푧(1))
푃 (푍(1) = 푧(1)|푋(1) = 푥(1)) = 푃 (푍(1) = 1)푍(1)푒1 + 푃 (푍(1) = 0)(1 −푍(1))1 − 푒1
and the stabilized IPTW weights for the second event are
푠푤2 =
푃 (푍(1) = 푧(1))
푃 (푍(1) = 푧(1), 푋(1) = 푥(1))
⋅
푃 (푍(2) = 푧(2)|푍(1) = 푧(1))
푃 (푍(2) = 푧(2)|푋(2) = 푥(2), 푍(1) = 푧(1))
= 푝11
푍(1)푍(2)
푒1푒2
+ 푝10
푍(1)(1 −푍(2))
푒1(1 − 푒2)
+ 푝01
(1 −푍(1))푍(2)
(1 − 푒1)푒2
+ 푝00
(1 −푍(1))(1 −푍(2))
(1 − 푒1)(1 − 푒2)
where 푝푖푗 = 푃 (푍(1) = 푖, 푍(2) = 푗)
10 11.
The reason why we consider the stabilized weights is that the conventional weights sometimes result in extremely large
weights for a few subjects. As a result, these subjects dominate the weighted analysis, and this results in unstable estimation of
the marginal hazard ratio. In addition, the use of the conventional weights sometimes also leads to rather large variance for the
conventional IPTW estimator10.
2.2 Time-Fixed Treatment and Covariates
We start with the simplest case where there are two independent gap times푊1 and푊2 for each subject. For simplicity we assume
푋 is a 1-dimensional scalar. Figure 112 illustrates the relationship among푋,푍,푊1 and푊2. Our goal is to use propensity score
methods to consistently estimate the marginal treatment effect. In this setting we assume treatment and covariates are fixed over
time, so we use푍 and푋 without the 푗 notation. Define 푒 to be the probability of treatment conditional on covariates. We regress
treatment indicator 푍 on 푋 to obtain the estimated propensity score 푒̂:
푒̂ = 푒푥푝푖푡
(
훼̂0 + 훼̂1푥
)
To estimate the overall marginal treatment effect, we regress the survival outcomes푊1 and푊2 on the treatment status푍 through
a weighted Cox proportional hazards model with the stabilized weights as defined in Section 2.1:
ℎ푗(푤|푥, 푧) = ℎ0(푤)푒훽푚푧
where 푗 = 1, 2.
푍
푊1 푊2
푋
FIGURE 1 Causal graph for time-fixed treatment and covariate
We perform a simulation study to examine the numerical performance of the IPTW estimator using the stabilized weights. For
simplicity, we generate a standard normal covariate 푋. For each subject we generate a treatment probability through a logistic
regression model:
휋 = 푒푥푝푖푡
(
훼0 + 훼1푥
)
Then we generate a treatment status for each individual 푍 ∼ 퐵푒푟푛표푢푙푙푖(휋). We set 훼0 to be -1.1392 by a bisection approach to
achieve an overall treatment prevalence of 25%5. Here 훼1 represents the log odds ratio of receiving treatment per unit increase
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in 푋 and we set it to be log(1.5). For each subject we simulate two independent gap times푊1 and푊2 from a Cox proportional
hazards model. We choose the baseline hazard to be an exponential distribution with 휆 = 1. Hence, the hazard takes the form:
ℎ푗(푤|푥, 푧) = 푒훽푐푧+훽1푥
where 푗 =1 ,2. The association parameter between 푋 and푊푗 is 훽1, and is set to log(1.5). The simulation algorithm for푊1 and
푊2 is as follows
13
• Simulate two independent standard uniform distribution 푢1 and 푢2
• Simulate 푤1 =
−푙표푔(푢1)
푒훽
푐푧+훽1푥
and 푤2 =
−푙표푔(푢2)
푒훽
푐푧+훽1푥
The true marginal hazard ratio is determined as follows: For each subject we simulate both potential outcomes for both gap
times under treatment and control conditions. Then we regress the gap time on treatment status to obtain the log of the true
marginal hazard ratio 훽푚. The above data generation method is based on a conditional hazard ratio 푒훽
푐
. However, the IPTW
estimator estimates the marginal hazard ratio. To this end, we use a bisection approach to determine 훽푐 that induces the specified
marginal hazard ratio 푒훽
푚 5.
To estimate 훽푚 for a given simulated dataset, first we obtain the estimated propensity score 푒̂ through a logistic regression
model. Then we calculate the stabilized weights 푠푤 = 푃 (푍=1)푍
푒
+
푃 (푍=0)(1−푍)
1−푒
. Finally we regress the gap times on the treatment
indicator through a weighted Cox proportional hazards model:
ℎ푗(푤|푥, 푧) = ℎ0(푤)푒훽푚푧
Doing this allows us to estimate the marginal treatment effect. Since weighting artificially creates a cluster for each subject,
inducing a within-subject correlation, the naÃŕve variance estimator often fails to correctly estimate the variance of 훽̂푚 10. To
address this issue, we use the robust variance estimator proposed by Lin14 15.
2.3 Time-Varying Covariates
Next we consider the case where covariates change over time while treatment is fixed. Assume 푋(푗) is a 1-dimensional scalar.
The relationship among these variables is illustrated in Figure 2. Due to the presence of time-varying covariates, the marginal
hazard ratio may differ for the two events. The methodology for estimating the marginal hazard ratio is as follows: First we
estimate the propensity score through a logistic regression model:
푒̂ = 푒푥푝푖푡
(
훼̂0 + 훼̂1푥(1)
)
Then to estimate the marginal hazard ratio for the first and second event, we run a weighted Cox proportional hazards model
using the stabilized weights, whose hazard takes the form:
ℎ푗(푤|푥(푗), 푧(푗)) = ℎ0푗 (푤)푒훽푚푗 푧
where 푗 = 1, 2.
푍(1)
푊1 푊2
푋(1) 푋(2)
FIGURE 2 Causal graph for time-varying covariates
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We perform the following simulation study to examine the numeric performance of the proposed IPTW estimator. We follow
the same data generationmethods described in Section 2.2 for the first gap time. Based on the first gap time푊1 and the covariate
푋(1), we simulate the 푋(2) covariate a second dependent gap time푊2 as follows
13:
• Simulate a standard uniform random variable 푢2
• Simulate a random variable 푣 ∼ 푁(0, 16) independent of 푥(1) and 푢2
• Set 푥(2) = 푥(1) + 푣
• Simulate 푤2 =
−푙표푔(푢2)
푒훽
푐푧+훽1푥(2)
Although the above data generation for the second gap time results in the same conditional hazard ratio 푒훽
푐
for both gap times,
the marginal hazard ratio may differ. For a given conditional hazard ratio 푒훽
푐
, we determine the true marginal hazard ratio for
the second event using a similar method to that discussed in Section 2.2.
We obtain the estimated propensity score 푒̂, along with the stabilized weights for both gap times. Then, we regress the gap
time 푊푗 on treatment indicator 푍(푗) through a weighted Cox proportional hazards model with the stabilized weights 푠푤1 and
푠푤2 to estimate the marginal hazard ratio for the first and second event.
ℎ푗(푤|푥(푗), 푧) = ℎ0푗 (푤)푒훽푚푗 푧
where 푗 = 1, 2. Here 훽푚푗 denotes the log marginal hazard ratio for the 푗푡ℎ gap time. Finally, we estimate the variance of 훽̂푚1 and
훽̂푚2 using both the naÃŕve variance estimator and the robust variance estimator.
2.4 Time-Varying Treatment and Covariates
Wemake further extensions by considering both time-varying treatment and covariates. Assume푋(푗) is a 1-dimensional scalar.
In such a setting, treatment status of the second event푍(2) is dependent on treatment status of the first event and covariate value
at the start of the second gap time 푋(2). Figure 3 illustrates the relationship among these variables. In this setting due to time-
varying treatment, for each subject we need to estimate two propensity scores. This can be done through the following logistic
regression models:
푒̂1 = 푒푥푝푖푡
(
훼̂0 + 훼̂1푥(1)
)
푒̂2 = 푒푥푝푖푡
(
훾̂0 + 훾̂1푥(2) + 훾̂2푧(1)
)
Then we estimate the marginal hazard ratio for the first and second gap time through the following weighted Cox proportional
hazards model using the stabilized weights 푠푤1 and 푠푤2:
ℎ푗(푤|푥(푗), 푧(푗)) = ℎ0푗 (푤)푒훽푚푗 푧(푗)
We illustrate our methodology for estimating the marginal treatment effect through a simulation study. We use the previously
discussed data generation methods for the first gap time. We consider the following dependence relationship between 푋(1) and
푋(2):
푍(1) 푍(2)
푊1 푊2
푋(1) 푋(2)
FIGURE 3 Causal graph for time-varying treatment and covariate
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푋(2) = 푋(1) + 푌
where 푌 ⟂ 푋(1) and 푌 ∼ 푁(0, 16).
The above data generation technique results in a correlation of 0.24 between 푋(1) and 푋(2). Then, we simulate treatment
status for the second gap time 푍(2) as follows. First we simulate a treatment probability through a logistic regression model:
푙표푔푖푡(휋2) = 훾0 + 훾1푥(2) + 훾2푧(1)
We set 훾1 to log(1.5) and 훾2 to log(1.5). Hence the log odds ratio of receiving treatment when t = 2 is 1.5 per one unit increase
in푋(2) keeping treatment at t = 1 the same. We allow treatment prevalence for the second event to be 25% or 50%. We set 훾0 to
be -1.7233 to achieve an overall treatment prevalence of 25% and -0.1000 to achieve an overall treatment pravalence of 50% for
the second event16. Having set all the parameters for the treatment model, we generate treatment status 푍(2) ∼ 퐵푒푟푛표푢푙푙푖(휋2).
We simulate the first and second gap time푊1 and푊2 from a Cox proportional hazards model, whose hazard takes the form:
ℎ푗(푤|푥(푗), 푧(푗)) = ℎ0(푤)푒훽푐푧(푗)+훽1푥(푗)
We follow the similar method to that described in Section 2.2 to obtain the true marginal hazard ratio for both gap times.
For a given simulated dataset, to estimate the marginal hazard ratio for both gap times, first we obtain the estimated propensity
score 푒̂1 and 푒̂2 through the following logistic regression models:
푒̂1 = 푒푥푝푖푡
(
훼̂0 + 훼̂1푥(1)
)
and
푒̂2 = 푒푥푝푖푡
(
훾̂0 + 훾̂1푥(2) + 훾̂2푧(1)
)
Then we regress the first gap time on treatment indicator 푍(1) through a Cox proportional hazards model using the stabilized
weights 푠푤1 from Section 2.1 to obtain the estimated marginal hazard ratio 푒
훽̂푚1 for the first gap time. We run another weighted
Cox proportional hazards model to regress the second gap time on treatment indicator푍(2) using the stabilized weights 푠푤2 to
obtain the estimated marginal hazard ratio 푒훽̂
푚2 for the second gap time. The hazard takes the form:
ℎ푗(푤|푥(푗), 푧(푗)) = ℎ0푗 (푤)푒훽푚푗 푧(푗)
where 푗 = 1, 2. Finally, we estimate the variance of 훽̂푚1 and 훽̂푚2 using both the naÃŕve variance estimator and the robust variance
estimator.
2.5 Administrative Censoring
Often we have to deal with censored recurrent data where each subject experiences a different number of recurrent events. When
censoring is a time-dependent confounder, previous methods for estimating the marginal treatment effect without adjustments
for censoring may yield biased results. To this end we incorporate weights for censoring and we examine the performance of
the IPTW estimator in the presence of censoring. We incorporate an administrative censoring time 휏. We define the censoring
indicator 훿1 = 퐼(푤1 ≤ 휏) and 훿2 = 퐼(푤1 +푤2 ≤ 휏). We can treat (푍(푖), 훿푖) as a treatment vector at the start of the 푖
푡ℎ gap time.
Thus, intuitively the IPTW weights are the inverse of the probability of treatment path of the subject.
The stabilized censoring weights are10
푠푤
†
1
=
푃 (훿1 = 1)
푃 (훿1 = 1|푥(1), 푧(1))
푠푤
†
2
=
푃 (훿1 = 1)
푃 (훿1 = 1|푥(1), 푧(1)) ⋅ 푃 (훿2 = 1|훿1 = 1)푃 (훿2 = 1|훿1 = 1, 푥(2), 푧(2))
We allow the administrative censoring time to be 휏 = 1 or 0.25. When 휏 = 1, approximately 30% of the subjects are censored
for the first event and approximately 60% of the subjects are censored for the second event. When 휏 = 0.25, approximately 70%
of the subjects are censored for the first event and approximately 90% of the subjects are censored for the second event. We use
the stabilized weights defined above to estimate the marginal hazard ratio and its standard errors for the second gap time. The
simulation results are available in Table 5-6.
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TABLE 1 Marginal and conditional log hazard ratios used in simulation study
True log True marginal True log True log True marginal
marginal HR 훽푚1 HR 푒훽
푚1 conditional HR 훽푐 marginal HR 훽푚2 HR 푒훽
푚2
0 1 0 0 1
0.4055 1.5 0.4599 0.2085 1.2318
0.6931 2 0.7830 0.3551 1.4263
0.9163 2.5 1.0313 0.4686 1.5978
1.0986 3 1.2331 0.5616 1.7535
†HR: Hazard ratio
3 SIMULATION RESULTS
We allow the true marginal hazard ratio for the first gap time 푒훽
푚1 to be 1, 1.5, 2, 2.5 and 3. We determine the corresponding 훽푐
that results in the specified marginal hazard ratio using a bisection approach5. For a given 훽푐 , there is also a corresponding true
marginal hazard ratio for the second gap time 푒훽
푚2 . We summarize the relationship in Table 1.
For each of the three simulation settings, we simulate 1,000 datasets, each consisting of 10,000 subjects. In each of the 1,000
simulated datasets, we record the estimated log marginal hazard ratio for both gap times 훽̂1(푗) and 훽̂2(푗), along with its naÃŕve
standard error 휎̂1(푗) and 휎̂2(푗). We record the average estimated logmarginal hazard ratio 훽̂
푚푘
=
1
1,000
∑1,000
푗=1
훽̂푘(푗) for 푘= 1, 2.We
define the average bias of the log marginal hazard ratio as: 훽̂
푚푗
−훽푚푗
훽푚푗
⋅100%where 푗 = 1, 2. Then we determine the average standard
error of the log hazard ratio across the 1,000 datasets: 퐴푆퐸푘 = 휎̂푘 =
1
1,000
∑1,000
푗=1
휎̂푘(푗) where 푘 = 1, 2. We also determine the
empirical standard error of the 1,000 estimated logmarginal hazard ratios for both gap times:퐸푆퐸푘 =
√∑1,000
푗=1
(
훽̂푘(푗)−훽
푚푘
)2
1,000−1
where
푘 = 1, 216. If the variance of 훽̂푚1 and 훽̂푚2 are correctly estimated, the average standard error should be close to the empirical
standard error. For each of the three simulation settings, we record the average estimated log marginal hazard ratio, along with
its average bias, average naÃŕve standard error, average robust standard error and empirical standard error. We summarize the
simulation results for the second gap time in tables below. We repeat the same procedures for a sample size of 500 and due to
limited space, we move the results for scenarios with sample size of 500 to web material.
From the estimating equation theory, when there is no censoring the IPTW estimate 훽̂푚푗 converges to the log of the true log
marginal hazard ratio 훽푚푗 as the sample size 푛 goes to infinity. Austin (2012)5 showed that without the presence of censoring, the
IPTW estimator estimated the marginal hazard ratio for time to event data with negligible bias with sample size of 10,000. For
our simulation studies with recurrent data, we obtained similar results. Table 2-4 summarize the results for scenarios without
the presence of censoring. As we can see from the tables, the average bias is very close to 0 for independent gap time and
time-varying covariates scenarios, while the bias is slightly higher for time-varying treatment and covariates scenarios. Hence
it is safe to say that the IPTW estimator estimates the marginal hazard ratio for the second event with minimal bias when
the sample size is 10,000. For simulation scenarios with 500 subjects, the bias is substantially higher compared to those with
10,000 subjects, especially for time-varying treatment and covariates scenarios. Thus, a sample size of 500 does not suffice to
estimate the true marginal hazard ratio. Keeping sample size the same, the prevalence of treatment also impacts the degree of
bias in estimating the marginal hazard ratio. We observe that the bias is lower when the treatment prevalence is 50%. Table
5-6 summarize the results for scenarios with an administrative censoring time. With an administrative censoring time of 1, the
IPTW estimator results in a moderate degree of bias in estimating the true marginal hazard ratio. Moreover, the bias tends to
decrease as the true marginal hazard ratio is higher. As we increase the proportion of subjects being censored by setting 휏 to
0.25, the IPTW estimate tends to be further removed from the true marginal hazard ratio, regardless how large the sample size
is. It is likely the estimate converges to another quantity other than the true marginal hazard ratio. However, it is not clear what
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TABLE 2 Simulation results for independent gap times, sample size = 10,000
Prevalence = 25%:
True log True marginal Estimated log Estimated Avg
marginal HR 훽푚2 HR 푒훽
푚2 marginal HR 훽̂
푚2
marginal HR 푒훽̂
푚2
Bias ASE ESE RSE
0 1 0.0002 1.0002 -0.02% 0.0163 0.0175 0.0196
0.4055 1.5 0.4091 1.5055 0.89% 0.0165 0.0191 0.0207
0.6931 2 0.7009 2.0156 1.13% 0.0168 0.0200 0.0216
0.9163 2.5 0.9278 2.5289 1.26% 0.0172 0.0209 0.0223
1.0986 3 1.1149 3.0493 1.48% 0.0175 0.0206 0.0230
Prevalence = 50%:
0 1 0.0000 1.0000 0.00% 0.0141 0.0140 0.0156
0.4055 1.5 0.4050 1.4993 -0.12% 0.0144 0.0143 0.0164
0.6931 2 0.6927 1.9991 -0.06% 0.0148 0.0153 0.0174
0.9163 2.5 0.9172 2.5023 0.10% 0.0153 0.0165 0.0182
1.0986 3 1.0989 3.0009 0.03% 0.0157 0.0166 0.0190
† HR: Hazard ratio
‡ ASE: Average standard error
†† ESE: Empirical standard error
†‡ RSE: Average robust standard error
TABLE 3 Simulation results for time-varying covariates, sample size = 10,000
Prevalence = 25%:
True log True marginal Estimated log Estimated Avg
marginal HR 훽푚2 HR 푒훽
푚2 marginal HR 훽̂
푚2
marginal HR 푒훽̂
푚2
Bias ASE ESE RSE
0 1 -0.0004 0.9996 -0.04% 0.0231 0.0244 0.0247
0.2085 1.2318 0.2104 1.2342 0.91% 0.0232 0.0255 0.0257
0.3551 1.4263 0.3619 1.4360 1.91% 0.0232 0.0265 0.0266
0.4686 1.5978 0.4803 1.6166 2.50% 0.0233 0.0276 0.0274
0.5616 1.7535 0.5797 1.7855 3.22% 0.0235 0.0270 0.0281
Prevalence = 50%:
0 1 -0.0059 0.9941 -0.59% 0.0200 0.0195 0.0205
0.2085 1.2318 0.2079 1.2311 -0.29% 0.0201 0.0205 0.0207
0.3551 1.4263 0.3551 1.4263 0.00% 0.0202 0.0216 0.0212
0.4686 1.5978 0.4681 1.5970 -0.11% 0.0203 0.0216 0.0216
0.5616 1.7535 0.5605 1.7515 -0.20% 0.0204 0.0221 0.0220
† HR: Hazard ratio
‡ ASE: Average standard error
†† ESE: Empirical standard error
†‡ RSE: Average robust standard error
the IPTW estimator is estimating in the presence of censoring. Therefore, we can conclude that the IPTW estimator results in
biased estimation of the true marginal hazard ratio. For variance estimation, our results are in line with that of Austin’s16. Due
to the within-subject correlation, the naÃŕve variance estimator often tends to substantially underestimate the variance of the
IPTW estimator14. The robust variance estimator generally results in negligible bias in estimating the variance for independent
gap time and time-varying covariate scenarios. The use of robust variance estimator results in minor bias for other scenarios,
and the bias is generally within 15%, which is still a huge improvement over the naÃŕve variance estimator.
AUTHOR ONE ET AL 9
TABLE 4 Simulation results for time-varying treatment and covariates, sample size = 10,000
Prevalence = 25%:
True log True marginal Estimated log Estimated Avg
marginal HR 훽푚2 HR 푒훽
푚2 marginal HR 훽̂
푚2
marginal HR 푒훽̂
푚2
Bias ASE ESE RSE
0 1 0.0159 1.0160 1.60% 0.0232 0.0953 0.0827
0.2085 1.2318 0.2230 1.2498 6.95% 0.0233 0.1049 0.0922
0.3551 1.4263 0.3701 1.4479 4.22% 0.0234 0.1235 0.0983
0.4686 1.5978 0.4984 1.6460 6.36% 0.0235 0.1237 0.0992
0.5616 1.7535 0.5957 1.8142 6.07% 0.0236 0.1264 0.1025
Prevalence = 50%:
0 1 0.0050 1.0050 0.50% 0.0201 0.0475 0.0501
0.2085 1.2318 0.2132 1.2376 2.25% 0.0201 0.0549 0.0547
0.3551 1.4263 0.3598 1.4330 1.32% 0.0203 0.0636 0.0586
0.4686 1.5978 0.4779 1.6127 1.98% 0.0204 0.0606 0.0600
0.5616 1.7535 0.5716 1.7711 1.78% 0.0206 0.0654 0.0629
† HR: Hazard ratio
‡ ASE: Average standard error
†† ESE: Empirical standard error
†‡ RSE: Average robust standard error
TABLE 5 Simulation results for time-varying treatment and covariates with administrative censoring time 휏 = 1, sample size
= 10,000
Prevalence = 25%:
True log True marginal Estimated log Estimated Avg
marginal HR 훽푚2 HR 푒훽
푚2 marginal HR 훽̂
푚2
marginal HR 푒훽̂
푚2
Bias ASE ESE RSE
0 1 0.0026 1.0026 0.26% 0.0418 0.0591 0.0669
0.2085 1.2318 0.2396 1.2707 14.92% 0.0380 0.0603 0.0666
0.3551 1.4263 0.3938 1.4826 10.90% 0.0360 0.0612 0.0672
0.4686 1.5978 0.5014 1.6510 7.00% 0.0347 0.0620 0.0685
0.5616 1.7535 0.5904 1.8047 5.13% 0.0339 0.0646 0.0687
Prevalence = 50%:
0 1 0.0018 1.0018 0.18% 0.0363 0.0534 0.0614
0.2085 1.2318 0.2334 1.2629 11.94% 0.0338 0.0531 0.0598
0.3551 1.4263 0.3861 1.4712 8.73% 0.0324 0.0493 0.0586
0.4686 1.5978 0.4964 1.6428 5.93% 0.0316 0.0506 0.0583
0.5616 1.7535 0.5750 1.7771 2.39% 0.0311 0.0497 0.0573
† HR: Hazard ratio
‡ ASE: Average standard error
†† ESE: Empirical standard error
†‡ RSE: Average robust standard error
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TABLE 6 Simulation results for time-varying treatment and covariates with administrative censoring time 휏 = 0.25, sample
size = 10,000
Prevalence = 25%:
True log True marginal Estimated log Estimated Avg
marginal HR 훽푚2 HR 푒훽
푚2 marginal HR 훽̂
푚2
marginal HR 푒훽̂
푚2
Bias ASE ESE RSE
0 1 0.0032 1.0032 0.32% 0.0984 0.1149 0.1201
0.2085 1.2318 0.2972 1.3461 42.54% 0.0843 0.1054 0.1107
0.3551 1.4263 0.4891 1.6308 37.74% 0.0761 0.1023 0.1050
0.4686 1.5978 0.6240 1.8664 33.16% 0.0705 0.0958 0.1007
0.5616 1.7535 0.7333 2.0819 30.57% 0.0666 0.0945 0.0978
Prevalence = 50%:
0 1 0.0138 1.0139 1.38% 0.0855 0.1669 0.1612
0.2085 1.2318 0.2944 1.3423 41.20% 0.0762 0.1556 0.1529
0.3551 1.4263 0.4947 1.6400 39.31% 0.0709 0.1419 0.1441
0.4686 1.5978 0.6305 1.8785 34.55% 0.0669 0.1371 0.1389
0.5616 1.7535 0.7323 2.0799 30.40% 0.0639 0.1377 0.1348
† HR: Hazard ratio
‡ ASE: Average standard error
†† ESE: Empirical standard error
†‡ RSE: Average robust standard error
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4 DISCUSSION
We conducted an extensive series of Monte Carlo simulations to examine the performance of the inverse probability of treatment
weighting (IPTW) method for estimating the marginal hazard ratio in the context of recurrent events. We briefly summarize our
simulation results and discuss what can be done in subsequent research.
Previous research has shown that the inverse probability of treatment weighting (IPTW)method results in unbiased estimation
of the marginal hazard ratio for time to event data5. We made a step further to investigate the performance of the IPTWmethod
for estimating marginal hazard ratio for recurrent data. We found that without the presence of censoring, the IPTW estimator
consistently estimated the marginal hazard ratio for the first and second event across all scenarios. However, sample size and
treatment prevalence both had an impact on the accuracy of the estimation of the marginal hazard ratio. Though the IPTW
estimator is asymptotically unbiased, the estimate could be biased for studies with small sample size. Therefore, we recommend
researchers use the IPTW estimator to estimate the marginal hazard ratio only when the sample size is sufficiently large. In the
presence of censoring, we observed from the simulation results that the IPTW estimator resulted in biased estimation of the
marginal hazard ratio. The degree of bias tended to be greater as we increased the proportion of subjects being censored. The
estimate seemed to converge to another quantity, however, we are unsure of what it converges to and the interpretations of the
estimate remains unclear. Variance estimattion plays an important role in determining the optimal sample size if one would
like to control the average bias of the IPTW estimate to be within a certain range. Austin (2016) showed that the use of the
robust variance estimator significantly improved accuracy of variance estimation16. Based on our simulation results, it turned
out that the robust variance estimator approximated the variance reasonably well within 10% bias for most scenarios, while the
naÃŕve variance estimator often substantially underestimated the variance. Due to time constraint, we did not consider the use
of bootstrap variance estimator, which was proven to have similar performance to that of the robust variance estimator for time
to event data5.
Certainly there are some limitations in our simulation studies. One of the limitations is that we only considered one dependence
relationship between 푋(1) and푋(2). Though the IPTW estimator consistently estimates the marginal hazard ratio for recurrent
data, the converging rate may differ for different dependence relationship between푋(1) and푋(2). If the researcher would like to
control the estimation bias within a certain range for a study, it would be difficult to figure out the optimal sample size. Another
limitation is that we only considered the case where푋(1) follows a standard normal distribution. Further research can be done to
investigate the behaviour of the IPTW estimator when 푋(1) is binary or categorical. We could also incorporate more variables
or even consider the possibility of dependence relationship among these variables. One could also consider other propensity
score methods such as matching, stratification to estimate the marginal hazard ratio.
To summarize, based on the simulation results, we recommend researchers use the IPTW estimator to estimate the marginal
hazard ratio with the robust variance estimator for observational recurrent data without the presence of censoring. However,
researchers should be aware that though the IPTW estimator is asymptotically unbiased, when dealing with small samples the
IPTW estimator may result in bias in estimating the marginal hazard ratio. To this end, extra efforts should be paid to determine
the minimal sample size. In the presence of censoring, the IPTW method results in biased estimation of the marginal hazard
ratio, and the degree of bias is related to the proportion of subjects being censored. For this reason, the IPTW estimator should
not be used in the presence of censoring. Subsequent research should investigate methods for estimating the marginal hazard
ratio or figure out what the IPTW estimator estimates in the presence of censoring. Further extensions can be made to settings
with multiple events and the stabilized weights can be formulated in the similar way to that described in Section 2.110.
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